Transcriptional and epigenetic regulation of microglia in substance use disorders

Samara J Vilca1, Alexander V Margetts2, Tate A Pollock1

  • 1Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL 33136, United States of America; Center for Therapeutic Innovation, University of Miami Miller School of Medicine, Miami, FL 33136, United States of America.

Insights

Microglia, the brain's immune cells, are increasingly recognized for their role in substance use disorders. This review explores how epigenetic changes in microglia influence drug-taking behaviors.

Area of Science:

  • Neuroscience
  • Immunology
  • Genetics

Background:

  • Microglia are key immune cells in the central nervous system.
  • Emerging evidence implicates microglia in regulating substance use disorder (SUD) behaviors.
  • The epigenetic mechanisms underlying microglial changes in SUD are not fully understood.

Purpose of the Study:

  • To review the role of microglia in SUD.
  • To focus on microglial transcriptome alterations and epigenetic regulation in SUD.
  • To discuss advancements in studying microglial molecular mechanisms.

Main Methods:

  • Literature review of recent evidence on microglia and SUD.
  • Analysis of studies focusing on microglial gene expression and epigenetics.
  • Discussion of technical advances in low-input chromatin profiling.

Main Results:

  • Microglia play a significant role in various aspects of substance use disorder.
  • Epigenetic modifications are crucial regulators of microglial gene expression changes related to drug-taking.
  • Novel molecular mechanisms in microglia are being uncovered.

Conclusions:

  • Microglia are critical players in the neurobiology of substance use disorders.
  • Epigenetic regulation of the microglial transcriptome is a key area for understanding SUD.
  • Further research and technological advancements are needed to fully elucidate these mechanisms.